Our further study about OICR-9429 in the AOM/DSS-induced CRC model indicated that repression of Mll1 complex up-regulated anti-tumor immune response in CRC, supporting that MLL1 activity on m3Es is associated with tumor immunity in CRC. Here, KMT2A is linked to colorectal carcinoma.